Mass. life science firms get $3.4m in state loans
Seven early-stage life sciences companies, working in areas ranging from cancer drugs to treatments for spinal cord injuries to tests for genetic disorders, were awarded a total of $3.4 million in loans yesterday under the state's $1 billion life sciences initiative. (Full article: 376 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
